Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Thursday, November 10 • 13:30 - 15:00
Funding our future: Policy for sustainable, equitable funding in health research / Financer notre avenir : politiques en faveur de la répartition équitable d’un financement pérenne pour la recherche en santé

Sign up or log in to save this to your schedule and see who's attending!

Organized by, School of Public Policy, University of Calgary, Jennifer Zwicker

Health research includes biomedical, clinical, health systems services and social, cultural, environmental and population health research.  Findings in these areas are integral to the creation of new knowledge, development of more effective and more efficient health services and products resulting in improved quality of life of Canadians and a more efficient health system.  Canadian public research funding policy is struggling to keep pace with the increasing pressures on public research funding allocations within the health care discipline.

With a comprehensive review of federal support for fundamental science occurring in 2016, this will be dynamic and engaging panel that will draw on multiple perspectives to discuss how health research can be both more sustainable and equitable in Canada to maximize Canada’s health research potential. With discussion grounded in the funding trends for Canadian health research from the 1960s to present, panelists will focus on both the policies and priorities that guide health research investments and the principles and practices of the peer review process.

• Revisiting the policies and priorities that guide health research investments: The shift in health research policy in Canada to “mission-driven research” runs the risk of “short-termism”, where the quantity and type of research funded is focused on short-term results and is industry or priority driven (Lynch, 2015). An OECD report (2015) highlights that long-term funding for curiosity-driven research is a significant source of innovation and has high social return. Panelists will discuss how research-funding policy can become more sustainable and the importance of maintaining creativity.

• Revising principles and practices of the peer review process: How can the grant review process better address any potential bias in the way funding is approved? With recent changes to the peer review system for awarding federal research funding, members of the scientific community have concerns around the variability in success rates across career stages and potential unconscious biases due to gender and other characteristics that might come into play when research grants are awarded. Panellists will discuss what may be contributing to this and suggest areas where policy revision is needed.

Moderators
avatar for Jennifer Zwicker

Jennifer Zwicker

Director of Health Policy, School of Public Policy and Assistant Professor, Kinesiology, School of Public Policy, University of Calgary
Dr. Jennifer Zwicker is Manager of neurodevelopmental disability research in health policy at the University of Calgary, School of Public Policy. Supported by NeuroDevNet, the CHILD BRIGHT CIHR SPOR grant and the Sinneave Family Foundation, her research focuses on the socioeconomic impact of neurodevelopmental disability research and interventions as a means for informing evidence based policy development. Dr. Zwicker received her PhD... Read More →

Speakers
avatar for Krista Connell

Krista Connell

Chief Executive Officer, Nova Scotia Health Research Foundation
As Chief Executive Officer at Nova Scotia Health Research Foundation, Krista Connell has been instrumental in increasing research activity and capacity in Nova Scotia. She is a recognized champion of health research nationally and internationally. Krista regularly serves on external review committees for other health research-related organizations and is a member of various boards and working groups including the Canadian... Read More →
avatar for Danika Goosney

Danika Goosney

Director General, Science, Knowledge Translation and Ethics,, Canadian Institutes of Health Research.
Danika obtained a B.Sc. (Hons.) from St. Francis Xavier University.  She completed her Ph.D. at the University of British Columbia in the Department of Microbiology and Immunology and the Biotechnology Laboratory (now the Michael Smith Labs). She conducted her postdoctoral training as a CIHR Postdoctoral Fellow in the Department of Immunology at the Scripps Research Institute in La Jolla, California. Following her... Read More →
avatar for Michael Hendricks

Michael Hendricks

Assistant Professor, Department of Biology, McGill University
Michael Hendricks is an Assistant Professor in the Department of Biology at McGill University. He conducts fundamental research on how the environment and stress affect the development and function of the nervous system. Dr. Hendricks’ career has given him experience with funding systems in Singapore, the United States, and Canada. In response to recent changes at CIHR, he and others founded the Association of... Read More →
avatar for Holly Witteman

Holly Witteman

Department of Family and Emergency Medicine, Universite Laval
Holly Witteman is an Assistant Professor in the Faculty of Medicine, Université Laval, Quebec City, Canada, director of a research unit and a scientist at the Research Centre of the CHU de Québec. With an interdisciplinary background in mathematics, human factors engineering, human-computer interaction and decision sciences, her research is about the design and evaluation of digital media for health education... Read More →
avatar for Jim Woodgett

Jim Woodgett

Director of the Lunenfeld-Tanenbaum Research Institute,, Mount Sinai Hospital
Jim Woodgett, Ph.D. (Dundee U) moved to Canada in 1992 to work at the Ontario Cancer Institute. His biomedical research there focused on the signalling mechanisms that underscore malignant growth, degenerative diseases and diabetes. | | From 1995-2005, he was an International Scholar of the Howard Hughes Medical Institute and in 1997 was appointed Head of the Division of Experimental Therapeutics, where he held the Amgen Chair of Cancer... Read More →


Thursday November 10, 2016 13:30 - 15:00
Room 211

Attendees (18)